Literature DB >> 21573995

Histamine H3 receptor agonists decrease hypothalamic histamine levels and increase stereotypical biting in mice challenged with methamphetamine.

Junichi Kitanaka1, Nobue Kitanaka, F Scott Hall, George R Uhl, Tomohiro Tatsuta, Yoshio Morita, Koh-ichi Tanaka, Nobuyoshi Nishiyama, Motohiko Takemura.   

Abstract

The effects of the histamine H(3) receptor agonists (R)-α-methylhistamine, imetit and immepip on methamphetamine (METH)-induced stereotypical behavior were examined in mice. The administration of METH (10 mg/kg, i.p.) to male ddY mice induced behaviors including persistent locomotion and stereotypical behaviors, which were classified into four categories: stereotypical head-bobbing (1.9%), circling (1.7%), sniffing (14.3%), and biting (82.1%). Pretreatment with (R)-α-methylhistamine (3 and 10 mg/kg, i.p.) significantly decreased stereotypical sniffing, but increased stereotypical biting induced by METH, in a dose-dependent manner. This effect of (R)-α-methylhistamine on behavior was mimicked by imetit or immepip (brain-penetrating selective histamine H(3) receptor agonists; 10 mg/kg, i.p. for each drug). Hypothalamic histamine levels 1 h after METH challenge were significantly increased in mice pretreated with saline. These increases in histamine levels were significantly decreased by pretreatment with histamine H(3) receptor agonists, effects which would appear to underlie the shift from METH-induced stereotypical sniffing to biting.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21573995      PMCID: PMC4133108          DOI: 10.1007/s11064-011-0500-8

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  31 in total

1.  Histamine H(3) receptor-mediated inhibition of depolarization-induced, dopamine D(1) receptor-dependent release of [(3)H]-gamma-aminobutryic acid from rat striatal slices.

Authors:  J A Arias-Montaño; B Floran; M Garcia; J Aceves; J M Young
Journal:  Br J Pharmacol       Date:  2001-05       Impact factor: 8.739

2.  Improvement of spatial memory by (R)-alpha-methylhistamine, a histamine H(3)-receptor agonist, on the Morris water-maze in rat.

Authors:  S Rubio; A Begega; L J Santin; J L Arias
Journal:  Behav Brain Res       Date:  2002-02-01       Impact factor: 3.332

3.  Acute and chronic effects of methamphetamine on tele-methylhistamine levels in mouse brain: selective involvement of the D(2) and not D(3) receptor.

Authors:  S Morisset; C Pilon; J Tardivel-Lacombe; D Weinstein; W Rostene; C Betancur; P Sokoloff; J C Schwartz; J M Arrang
Journal:  J Pharmacol Exp Ther       Date:  2002-02       Impact factor: 4.030

Review 4.  Catecholamines in the brain as mediators of amphetamine psychosis.

Authors:  S H Snyder
Journal:  Arch Gen Psychiatry       Date:  1972-08

5.  Stereotyped activities produced by amphetamine in several animal species and man.

Authors:  A Randrup; I Munkvad
Journal:  Psychopharmacologia       Date:  1967

6.  A selective dopamine D4 receptor antagonist, NRA0160: a preclinical neuropharmacological profile.

Authors:  S Okuyama; N Kawashima; S Chaki; R Yoshikawa; T Funakoshi; S I Ogawa; Y Suzuki; Y Ikeda; T Kumagai; A Nakazato; M Nagamine; K Tomisawa
Journal:  Life Sci       Date:  1999       Impact factor: 5.037

7.  Histamine H3 receptor activation inhibits dopamine D1 receptor-induced cAMP accumulation in rat striatal slices.

Authors:  Enrique Sánchez-Lemus; José-Antonio Arias-Montaño
Journal:  Neurosci Lett       Date:  2004-07-08       Impact factor: 3.046

8.  Histamine h3 receptor antagonists potentiate methamphetamine self-administration and methamphetamine-induced accumbal dopamine release.

Authors:  Patrik Munzar; Gianluigi Tanda; Zuzana Justinova; Steven R Goldberg
Journal:  Neuropsychopharmacology       Date:  2004-04       Impact factor: 7.853

9.  Signal transduction by histamine in the cerebellum and its modulation by N-methyltransferase.

Authors:  Motohiko Takemura; Nobue Kitanaka; Junichi Kitanaka
Journal:  Cerebellum       Date:  2003       Impact factor: 3.847

10.  Pretreatment with l-histidine produces a shift from methamphetamine-induced stereotypical biting to persistent locomotion in mice.

Authors:  Junichi Kitanaka; Nobue Kitanaka; Tomohiro Tatsuta; Akio Miyoshi; Atena Koumoto; Koh-Ichi Tanaka; Nobuyoshi Nishiyama; Yoshio Morita; Motohiko Takemura
Journal:  Pharmacol Biochem Behav       Date:  2009-11-04       Impact factor: 3.533

View more
  3 in total

1.  Histamine H3 receptor antagonist JNJ-39220675 modulates locomotor responses but not place conditioning by dopaminergic drugs.

Authors:  Jenni Vanhanen; Marja Kinnunen; Saara Nuutinen; Pertti Panula
Journal:  Psychopharmacology (Berl)       Date:  2014-10-12       Impact factor: 4.530

Review 2.  Brain Histamine N-Methyltransferase As a Possible Target of Treatment for Methamphetamine Overdose.

Authors:  Junichi Kitanaka; Nobue Kitanaka; F Scott Hall; George R Uhl; Motohiko Takemura
Journal:  Drug Target Insights       Date:  2016-03-02

3.  Activation of carbonic anhydrase isoforms involved in modulation of emotional memory and cognitive disorders with histamine agonists, antagonists and derivatives.

Authors:  Gustavo Provensi; Alessio Nocentini; Maria Beatrice Passani; Patrizio Blandina; Claudiu T Supuran
Journal:  J Enzyme Inhib Med Chem       Date:  2021-12       Impact factor: 5.051

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.